Chronic intraventricular administration of 1-methyl-4-phenylpyridinium as a progressive model of Parkinson's disease

Parkinsonism and Related Disorders

Volumn 14, Issue SUPPL.2, 2008, Pages

  Sonsalla, Patricia K ^a   Zeevalk, Gail D ^a   German, Dwight C ^b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Chronic Parkinson's disease model; Dopamine; MPP+; Neurodegeneration; Rat; Stereology

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; DOPAMINE; GLUTATHIONE;

AMINO ACID BRAIN LEVEL; CELL INCLUSION; CELL LOSS; CHRONIC DRUG ADMINISTRATION; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GLIOSIS; LATERAL BRAIN VENTRICLE; NERVE DEGENERATION; NEUROCHEMISTRY; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVIEW; STEREOLOGY;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; HERBICIDES; HUMANS; INJECTIONS, INTRAVENTRICULAR; PARKINSON DISEASE;

EID: 47049106015     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.04.008     Document Type: Review

References (9)

1. Petroske E., Meredith G.E., Callen S., Totterdell S., and Lau Y.S. Mouse model of parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience 106 (2001) 589-601
2. Fornai F., Schluter O.M., Lenzi P., Gesi M., Ruffoli R., Ferrucci M., et al. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci U S A 102 (2005) 3413-3418
3. +). Exp Neurol 200 (2006) 172-183
4. Zeevalk G.D., Manzino L., Sonsalla P.K., and Bernard L.P. Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's disease. Exp Neurol 203 (2007 Feb) 512-520
5. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3 (2000) 1301-1306
6. Mizukawa K., Sora Y.H., and Ogawa N. Ultrastructural changes of the substantia nigra, ventral tegmental area and striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Res Commun Chem Pathol Pharmacol 67 (1990) 307-320
7. Song D.D., Shults C.W., Sisk A., Rockenstein E., and Masliah E. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. [see comment]. Exp Neurol 186 (2004) 158-172
8. Tanaka J., Nakamura H., Honda S., Takada K., and Kato S. Neuropathological study on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of the crab-eating monkey. Acta Neuropathol 75 (1988) 370-376
9. Trimmer P.A., Swerdlow R.H., Parks J.K., Keeney P., Bennett Jr. J.P., Miller S.W., et al. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp Neurol 162 (2000) 37-50